Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.694 USD | -2.99% | +10.30% | -40.85% |
May. 14 | Vincerx Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 26 | Tech Rally Boosts Exchange-Traded Funds, Equity Futures Pre-Bell Friday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.85% | 21.13M | |
+18.41% | 125B | |
+14.06% | 108B | |
-6.54% | 23.64B | |
+2.39% | 22.39B | |
-12.11% | 17.78B | |
-41.64% | 16.43B | |
-14.98% | 16.34B | |
+0.25% | 13.56B | |
+25.23% | 11.59B |
- Stock Market
- Equities
- VINC Stock
- News Vincerx Pharma, Inc.
- Cantor Fitzgerald Adjusts Vincerx Pharma's Price Target to $8 From $22, Reiterates Overweight Rating